Skip to main content
Top
Published in: Cancer Chemotherapy and Pharmacology 3/2018

01-03-2018 | Retraction Note

Retraction Note to: Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells

Authors: Hala U. Gali-Muhtasib, Mona Diab-Assaf, Makhluf J. Haddadin

Published in: Cancer Chemotherapy and Pharmacology | Issue 3/2018

Login to get access

Excerpt

The authors have retracted this article [1] because of overlap in images within the publication and with another previously published article [2]. It was brought to our attention that there are inconsistencies in Figs. 3, 5 and 6. The left middle panel in Fig. 3, labeled “Ctrl”, is the same as the left panel in Fig. 6, labeled “PD98059”, except that the latter is flipped upside down and right-left. In Fig. 5, the gel in the middle left panel labeled TGF-β2 has been cropped in two different ways and used in Figs. 2 and 3 of Harakeh et al. [2]. This has been investigated by the Internal Research Integrity panel of the American University of Beirut who recommended retraction of the article as the original data are not available. *All authors agree to this retraction. …
Metadata
Title
Retraction Note to: Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells
Authors
Hala U. Gali-Muhtasib
Mona Diab-Assaf
Makhluf J. Haddadin
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Cancer Chemotherapy and Pharmacology / Issue 3/2018
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-017-3515-2

Other articles of this Issue 3/2018

Cancer Chemotherapy and Pharmacology 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine